SeaStar Q1 Results: QUELIMMUNE Sales Up Fourfold Sequentially, Company Now Targeting Adult Market

benzinga.com/partner/news/25/05/45641502/seastar-q1-results-quelimmune-sales-up-fourfold-sequentially-company-now-targeting-adult-market

SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, is seeing double-digit growth in sales of QUELIMMUNE, which drove revenues for the…

This story appeared on benzinga.com, 2025-05-28 12:07:18.
The Entire Business World on a Single Page. Free to Use →